IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conquet, P.
Right arrow Articles by Le Douarec, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conquet, P.
Right arrow Articles by Le Douarec, J. C.

Investigative Ophthalmology & Visual Science, Vol 14, 772-775, Copyright © 1975 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Arachidonic acid-induced elevation of intraocular pressure and anti- inflammatory agents

P Conquet, B Plazonnet and JC Le Douarec

Arachidonic acid, a precursor of prostaglandin E2 subconjunctivally injected into rabbit eyes in concentrations of 0.8 to 5 per cent, produced a dose-related rise of intraocular pressure (IOP) similar to the one observed after topical administration of PGE2 in concentrations of 0.001 to 0.1 per cent. Indomethacin, a nonsteroidal anti- inflammatory agent, had an inhibitory effect when administered systemically or topically prior to arachidonic acid. Dose-response relationships were demonstrated by topical and oral administration of Indomethacin which, as expected, had no effect on PGE2. Dexamethasone did not exert any inhibitory effect on the increased IOP following arachidonic acid administration. Indomethacin applied topically readily penetrated into the aqueous humor in concentrations considerably above those appearing in the plasma, which justifies the use of this route of administration. Since prostaglandin (PG) appeared to be implicated in ocular inflammation, these findings underline the specificity of action of Indomethacin and suggest its use in the topical treatment of ocular inflammation.


This article has been cited by other articles:


Home page
IOVSHome page
Y. Hasegawa, J. Nishimura, N. Niiro, K. Hirano, T. Ishibashi, and H. Kanaide
Prostaglandin F2{alpha}, but Not Latanoprost, Increases the Ca2+ Sensitivity of the Pig Iris Sphincter Muscle
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4865 - 4871.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the Association for Research in Vision and Ophthalmology